A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus.
Abed
Yacine
Y
Research Center in Infectious Diseases of the CHUQ-CHUL, Québec City, Canada.
Goyette
Nathalie
N
Boivin
Guy
G
D000081:Acetamides / Q000494:pharmacology*; D000146:Acids, Carbocyclic; D000998:Antiviral Agents / Q000494:pharmacology; D003517:Cyclopentanes / Q000494:pharmacology*; D024882:Drug Resistance, Viral / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006146:Guanidines; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D009980:Influenza A virus / Q000187:drug effects* / Q000235:genetics; D020128:Inhibitory Concentration 50; D009154:Mutation; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000235:genetics; D053139:Oseltamivir; D011714:Pyrans; D011995:Recombination, Genetic; D012794:Sialic Acids / Q000494:pharmacology; D053243:Zanamivir
D000081:Acetamides; D000146:Acids, Carbocyclic; D000998:Antiviral Agents; D003517:Cyclopentanes; D004791:Enzyme Inhibitors; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir; C414210:peramivir